"We are the headquarters for an integrated network of premier investigational sites conducting clinical research studies. Many of our studies are for paid volunteers. Want to volunteer for a clinical trial? Check out our website to view our current studies in Raleigh, or view one of our other locations in North America to see if you may qualify for a trial. We work closely with and meet the needs of the biopharmaceutical, biotechnology, medical device, pharmaceutical industries and clinical research organizations. Clinical trials allow medical researchers to evaluate drug effectiveness and safety in a controlled environment. Wake Research is dedicated to conducting safe and successful studies."

During the past decade, M3 Wake Research conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "M3 Wake Research" #1 sponsor was "HemoSonics LLC" with 2 trials, followed by "Arena Pharmaceuticals" with 1 trials sponsored, "BioVie Inc." with 1 trials sponsored, "Cerevance Beta, Inc." with 1 trials sponsored and "Insud Pharma" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "M3 Wake Research" #1 collaborator was "Chemo Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "M3 Wake Research" are "Coagulation Disorder" (2 trials), "Migraine" (2 trials), "Parkinson Disease" (2 trials), "Alström Syndrome (AS)" (1 trials) and "Bardet Biedl Syndrome (BBS)" (1 trials). Many other conditions were trialed in "M3 Wake Research" in a lesser frequency.

Most popular intervention types in "M3 Wake Research" are "Drug" (8 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Placebos" (2 trials), "Quantra System" (2 trials), "CVN424 High Dose" (1 trials) and "CVN424 Low Dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "M3 Wake Research" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "M3 Wake Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in M3 Wake Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in M3 Wake Research, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".